SciSparc Ltd.
SPRC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001611746
No open-market purchases or sales by SciSparc Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $296.4K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding SciSparc Ltd. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 6 | 3 | −3 |
| Shares | 173.0K | 147 | −172.8K (−99.9%) |
| Value | $95.1K | $514 | −$94.6K (−99.5%) |
New holders (2)
Institutions that held SciSparc Ltd. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 109 | $382 | 0.00% |
| Bank of America Corp | 4 | $14 | 0.00% |
Sold out (5)
Institutions that held SciSparc Ltd. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Phoenix Holdings Ltd. | 113,156 | $62.1K |
| HRT Financial LP | 22,363 | $12.0K |
| Two Sigma Securities, LLC | 21,649 | $11.9K |
| Susquehanna International Group, LLP | 14,917 | $8.57K |
| Morgan Stanley | 2 | $1 |